Carcinoid Tumor

• FDA approval · 2024-07-01
  FDA Approved: KIT FOR THE PREPARATION OF INDIUM IN 111 PENTETREOTIDE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a kit for the preparation of Indium-111 pentetreotide used in imaging neuroendocrine tumors.

• FDA approval · 2023-06-30
  FDA Approved: OCTREOTIDE — Supplemental Application (Fresenius Kabi USA, LLC)

  The FDA approved a supplemental application for octreotide acetate filed by Fresenius Kabi USA, LLC.

• FDA approval · 2021-12-22
  FDA Approved: OCTREOSCAN — Supplemental Application (Curium US LLC)

  The FDA approved a supplemental application for OCTREOSCAN (Indium-111 pentetreotide) submitted by Curium US LLC.

• FDA approval · 2015-06-01
  FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

  The FDA approved a supplemental application for Somatuline Depot (lanreotide acetate) filed by Ipsen Biopharmaceuticals, Inc., updating the …

• FDA approval · 2014-05-19
  FDA Approved: SANDOSTATIN LAR DEPOT — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Sandostatin LAR Depot (octreotide acetate) from Novartis, resulting in an updated labeling to re…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-03-03
  FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for Octreotide acetate from Hikma Pharmaceuticals USA Inc., updating the regulatory status of the ge…